Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.dld.2024.08.042 | DOI Listing |
Front Oncol
November 2024
Department of Medical Oncology, Lu'an Hospital of Traditional Chinese Medicine Affiliated To Anhui University of Chinese Medicine, Lu'an, China.
Tislelizumab, as a PD-1 inhibitor, has demonstrated significant efficacy in cancer treatment. However, it may also induce immune-related adverse events (irAEs). This case report describes a patient who developed oral ulcers and dysphagia following treatment with tislelizumab, which was diagnosed as exfoliative esophagitis through endoscopic examination.
View Article and Find Full Text PDFDig Liver Dis
November 2024
The First College of Clinical Medical Science, China Three Gorges University, Yichang, China; Institute of Digestive Disease, China Three Gorges University, Yichang, China; Department of Gastroenterology, Yichang Central People's Hospital, Yichang, China. Electronic address:
Front Genet
May 2024
Department of Spleen and Stomach Diseases, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China.
Background: Esophageal cancer (EC) is a prevalent malignancy characterized by a low 5-year survival rate, primarily attributed to delayed diagnosis and limited therapeutic options. Currently, early detection of EC heavily relies on endoscopy and pathological examination, which pose challenges due to their invasiveness and high costs, leading to low patient compliance. The detection of DNA methylation offers a non-endoscopic, cost-effective, and secure approach that holds promising prospects for early EC detection.
View Article and Find Full Text PDFGastroenterol Rep (Oxf)
February 2024
Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Biomater Sci
October 2023
Center for Disease Biology and Integrative Medicine, School of Medicine, the University of Tokyo, Japan.
Endoscopic submucosal dissection (ESD) for the treatment of esophageal mucosal lesions often leads to postoperative stenosis, causing difficulty in swallowing, known as dysphagia. In this study, we developed an cross-linkable powder composed of alginate, gelatin, transglutaminase (TG), and calcium chloride ions (Ca), which can be administered through a 1.5 m-long and 3.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!